Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its high-content imaging technology and AI-powered analysis used to speed drug discovery ...

In his concluding remarks, Dr. Jitendra Singh reflected on the future of India’s economy, which he asserted would be ...

This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol ...

Researchers have developed a new artificial intelligence (AI) technique that brings machine vision closer to how the human brain processes images. Called Lp-Convolution, this method improves the ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

A team of researchers at the Medical Research Council Laboratory of Molecular Biology, in the U.K., has re-examined an old ...

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...

A Newcastle biotech company is set to expand its overseas presence after raising a further £750,000. Aelius Biotech’s laboratory gut model is used to trial new drugs and foodstuffs without the need ...

Wall Street opened the week with volatility as early gains let to a quick reversal. Trump threatened 50% tariffs on China and ended talks, intensifying tensions after Beijing's retaliatory 34% ...